Pumarola Felix, Marès Josep, Losada Isabel, Minguella Isabel, Moraga Fernando, Tarragó David, Aguilera Ulla, Casanovas Josep M, Gadea Gloria, Trías Elisenda, Cenoz Santiago, Sistiaga Alessandra, García-Corbeira Pilar, Pirçon Jean-Yves, Marano Cinzia, Hausdorff William P
Hospital Infantil Universitario Vall d'Hebrón, Barcelona, Spain.
Int J Pediatr Otorhinolaryngol. 2013 Aug;77(8):1231-6. doi: 10.1016/j.ijporl.2013.04.002. Epub 2013 Jun 6.
To prospectively identify the bacterial aetiology and antimicrobial susceptibility of problematic (recurrent and treatment failure) acute otitis media in Spanish children several years after the introduction of 7-valent pneumococcal conjugate vaccine.
Tympanocentesis or careful sampling of spontaneous otorrhoea was performed on children aged 3 to <36 months with recurrent acute otitis media, acute otitis media treatment failure or unresolved acute otitis media.
105 acute otitis media episodes (77 sampled by tympanocentesis, 28 otorrhoea samples) were evaluated: 46 recurrent, 35 treatment failures, 24 unresolved acute otitis media. 74 episodes (70.4%) had at least one bacterium identified on culture: Streptococcus pneumoniae was identified in 21 episodes, Haemophilus influenzae (all non-typeable) in 44, Streptococcus pyogenes in 2, Moraxella catarrhalis in 2. No statistically significant difference in bacterial aetiology by episode type was detected. Non-typeable H. influenzae was the most commonly isolated pathogen in all acute otitis media types and in all age sub-groups. Forty percent of S. pneumoniae isolates were multi-drug resistant. Pneumococcal serotype 19A was the most frequently identified serotype (7/21 episodes). Multi-drug resistance was found in 56% of 19A isolates. Of non-typeable H. influenzae isolates, 15% were ampicillin resistant and 13% were amoxicillin/clavulanate resistant. S. pneumoniae and non-typeable H. influenzae DNA were each detected in 57% of samples culture negative for these pathogens, including 12 co-infections.
Combining culture and polymerase chain reaction results, H. influenzae and S. pneumoniae may be implicated in 70% and 43% of clinically problematic bacterial acute otitis media episodes, respectively. The impact of new vaccines to prevent both S. pneumoniae and non-typeable H. influenzae acute otitis media may be substantial in this population and is worth investigating.
在引入7价肺炎球菌结合疫苗数年之后,前瞻性地确定西班牙儿童中难治性(复发性和治疗失败)急性中耳炎的细菌病因及抗菌药物敏感性。
对3至<36个月大、患有复发性急性中耳炎、急性中耳炎治疗失败或未治愈的急性中耳炎的儿童进行鼓膜穿刺术或仔细采集自发性耳漏样本。
评估了105例急性中耳炎发作(77例通过鼓膜穿刺术采样,28例耳漏样本):46例复发,35例治疗失败,24例未治愈的急性中耳炎。74例发作(70.4%)在培养中至少鉴定出一种细菌:21例发作中鉴定出肺炎链球菌,44例中鉴定出流感嗜血杆菌(均为不可分型),2例中鉴定出化脓性链球菌,2例中鉴定出卡他莫拉菌。未检测到发作类型之间细菌病因的统计学显著差异。不可分型流感嗜血杆菌是所有急性中耳炎类型和所有年龄亚组中最常分离出的病原体。40%的肺炎链球菌分离株对多种药物耐药。肺炎球菌19A血清型是最常鉴定出的血清型(21例发作中有7例)。56%的19A分离株存在多重耐药。在不可分型流感嗜血杆菌分离株中,15%对氨苄西林耐药,13%对阿莫西林/克拉维酸耐药。在这些病原体培养阴性的样本中,分别有57%检测到肺炎链球菌和不可分型流感嗜血杆菌DNA,包括12例合并感染。
结合培养和聚合酶链反应结果,流感嗜血杆菌和肺炎链球菌可能分别与70%和43%的临床上难治性细菌性急性中耳炎发作有关。新型疫苗预防肺炎链球菌和不可分型流感嗜血杆菌急性中耳炎对该人群的影响可能很大,值得研究。